• 
  Nicolas Adamus, Julien Edeline, Julie Henriques, Nadim Fares, Thierry Lecomte, et al.. First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma. JHEP Reports Innovation in Hepatology, 2025, 7 (2), pp.101279. ⟨10.1016/j.jhepr.2024.101279⟩. ⟨hal-04932838⟩
• 
  Amira Marouf, Sammara Chaubard, Raphaël Liévin, Jean-Marie Michot, Nicolas Molinari, et al.. Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA. HemaSphere, 2025, 9 (1), pp.4. ⟨10.1002/hem3.70081⟩. ⟨hal-04926143⟩
• 
  Yuchen Guo, Monica Gabola, Rossano Lattanzio, Conception Paul, Valérie Pinet, et al.. Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer. Journal of Clinical Investigation, 2021, 131 (4), ⟨10.1172/JCI131517⟩. ⟨hal-03152320⟩
• 
  Aurélie Jourdes, Elise Cellerin, Cyrille Touzeau, Stéphanie Harel, Blandine Denis, et al.. Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study. Clinical Microbiology and Infection, 2024, 30 (6), pp.764-771. ⟨10.1016/j.cmi.2024.02.023⟩. ⟨hal-04916309⟩
• 
  F. Giugliano, A. Bertaut, J. Blanc, A. L. Martin, M. Fournier, et al.. Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort. ESMO Open, 2024, 9 (12), ⟨10.1016/j.esmoop.2024.103994⟩. ⟨hal-04831746⟩
• 
  Anna Patrikidou, Loïc Chaigneau, Nicolas Isambert, Kyriaki Kitikidou, Ryan Shanley, et al.. Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA). BMC Cancer, 2020, 20 (1), pp.117. ⟨10.1186/s12885-020-6548-6⟩. ⟨hal-02872774⟩
• 
  Nicolas Girard, F. Guisier, A. Swalduz, S. van Hulst, E. Pichon, et al.. Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study. ESMO Open, 2024, 9 (12), ⟨10.1016/j.esmoop.2024.103968⟩. ⟨hal-04831085⟩
• 
  Vincent Rondeau, Maria Kalogeraki, Lilian Roland, Zeina Abou Nader, Vanessa Gourhand, et al.. CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism. Science Signaling, 2024, 17 (860), pp.eadl5100. ⟨10.1126/scisignal.adl5100⟩. ⟨hal-04786079⟩
• 
  Emily Connell, Émilie Gerard, Bénédicte Oules, Florence Brunet-Possenti, Anouck Lamoureux, et al.. Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma. Oncologist, 2024, 29 (9), pp.e1180-e1188. ⟨10.1093/oncolo/oyae085⟩. ⟨hal-04885378⟩
• 
  Stéphane Vignot, Audrey Bellesoeur, Carole Bouleuc, Romain Cohen, Baudouin Courtier, et al.. Actualités 2024 par le Comité dé rédaction du Bulletin du Cancer : congrès ASCO, ESMO et au-delà. Bulletin du Cancer, 2024, 112 (1), pp.19-34. ⟨10.1016/j.bulcan.2024.12.001⟩. ⟨hal-04883755⟩
• 
  Guy Gorochov, Jacques Ropers, Odile Launay, Karim Dorgham, Omaira da Mata-Jardin, et al.. Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination. JAMA Network Open, 2024, 7, ⟨10.1001/jamanetworkopen.2024.8051⟩. ⟨hal-04871351v2⟩
• 
  Sauyeun Shin, Remy Nicolle, Christine Jean, Rémi Samain, Mira Ayadi, et al.. Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer. bioRxiv : the preprint server for biology, 2020, 12 (11), pp.1447-1454.e4. ⟨10.1101/2020.12.23.424227⟩. ⟨hal-04858439⟩
• 
  Kevin Atsou, Anne Auperin, Jôel Guigay, Sébastien Salas, Sébastien Benzekry. Mechanistic Learning for Predicting Survival Outcomes in Head and Neck Squamous Cell Carcinoma. CPT: Pharmacometrics and Systems Pharmacology, 2024, ⟨10.1002/psp4.13294⟩. ⟨hal-04558029v2⟩
• 
  Cédric Rossi, Guillaume Manson, Amira Marouf, Aurélie Cabannes-Hamy, Emmanuelle Nicolas-Virelizier, et al.. Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines. European Journal of Cancer, 2024, European Journal of Cancer, 213, pp.115073. ⟨10.1016/j.ejca.2024.115073⟩. ⟨hal-04851826⟩
• 
  Camille Laurent, A Nicolae, C Laurent, F Le Bras, Corinne Haioun, et al.. JAK-STAT PATHWAY AND EPIGENETIC REGULATORS ARE CRITICAL PLAYERS IN BI-ALCL PATHOGENESIS?. International Conference on Malignant Lymphoma, 2019, Lugano, Switzerland. , Hematological Oncology, 37 (S2), pp.18-22, ⟨10.1002/hon.16_2630⟩. ⟨inserm-04831206⟩
• 
  Ingrid Masson, Laurène Larriviere, Marc-André Mahé, David Azria, Pascal Pommier, et al.. Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer. Clinical and Translational Radiation Oncology, 2024, 44, pp.100702. ⟨10.1016/j.ctro.2023.100702⟩. ⟨hal-04813716⟩
• 
  Pascal-Alexandre Thomas, Anne-Laure Couderc, David Boulate, Laurent Greillier, Aude Charvet, et al.. Early-stage non-small cell lung cancer beyond life expectancy: Still not too old for surgery?. Lung Cancer, 2021, 152, pp.86-93. ⟨10.1016/j.lungcan.2020.12.009⟩. ⟨hal-03526487⟩
• 
  Jean-Emmanuel Kurtz, Xavier Buy, Frédéric Deschamps, Erik Sauleau, Amine Bouhamama, et al.. CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment. European Journal of Cancer, 2021, 143, pp.78-87. ⟨10.1016/j.ejca.2020.10.035⟩. ⟨hal-03623642⟩
• 
  Elisa Gobbini, Anne Claire Toffart, Maurice Pérol, Jean-Baptiste Assié, Michaël Duruisseaux, et al.. Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients. Clinical Lung Cancer, 2020, 21 (5), pp.e497-e510. ⟨10.1016/j.cllc.2020.04.013⟩. ⟨hal-04728622⟩
• 
  Nicolas Penel, Olivier Mir, Jennifer Wallet, Isabelle Ray-Coquard, Axel Le Cesne, et al.. A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib. European Journal of Cancer, 2020, 126, pp.45-55. ⟨10.1016/j.ejca.2019.12.001⟩. ⟨hal-03623680⟩

395

400